Treatment for neovascular or wet age-related macular degeneration (nAMD) is an area where a change in Medicare Part B payment specific to this procedure has far more potential for substantial reductions in spending. (more…)
In this post we discuss whether individuals experiencing a reduction in out-of-pocket medical expenses risk when they become Medicare eligible are more likely to invest in the stock market.
There is room to modify the bundled payment models to address concerns raised by Secretary Price and others without damaging the integrity of the models. (more…)
MACRA assumes a wide range of attractive APM opportunities available to physicians, but the reality is that the opportunities are limited, especially for physicians in specialties outside of primary care. (more…)
A recent study found Medicare Fee-for-Service and Medicare Advantage patients have hospitalization and post-hospitalization costs and outcomes that are generally different. How do these outcomes translate to policy recommendations? (more…)
As payment models move towards non-fee-for-service systems, primary care providers will increasingly be positioned as the quarterbacks for the healthcare team. Guest contributors Bob Kocher and Anuraag Chigurupati discuss what this change means for specialists, hospitals, and health systems. (more…)
Alice Rivlin and Loren Adler outline five major takeaways from the 2016 Medicare Trustees Report. This blog post is part of the Schaeffer Initiative for Innovation in Health Policy, a collaboration between the Brookings Institution and the USC Schaeffer Center for Health Policy & Economics. (more…)
CPC+ has some very promising components, but also misses some compelling opportunities to further advance payment for primary care services. (more…)
The CPC+ACO model should be evaluated now as a possible path for smaller, independent physician practices.
The newly released proposed rule provides answers regarding the specifics of implementation of MIPS and the APM incentives. (more…)